Biote reports first quarter 2023 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the first quarter ended march 31, 2023. first quarter 2023 financial highlights, year-over-year: revenue of $44.8 million, a 20.7% increase gross profit margin of 69.1%, a 220-basis point increase net loss of $(21.4) million and gaap loss per share of $(0.39), primarily reflecting the impact of tr.
BTMD Ratings Summary
BTMD Quant Ranking